Science Explorer Back to mapMap
Discussion
Researcher · Scientific Centre of Monaco · Monaco

Christopher Montemagno

Christopher Montemagno publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Radiopharmaceutical Chemistry and Applications, Angiogenesis and VEGF in Cancer and Cancer Cells and Metastasis.

ORCID 0000-0002-5687-1812 OpenAlex
World rank
#1,599,182
of 7,710,434 ranked researchers
Rank in Monaco
#40
of 187
Works
112
Citations
754
Citations per work
6.7
h-index
17
i10-index 22Top 30% in Oncology
Christopher Montemagno

What does Christopher Montemagno research?

Christopher Montemagno's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (5%).

Health Sciences: 47 works · 42.3% of their workMedicine: 47 works · 42.3% of their workOncology: 20 works · 17.8% of their workPulmonary and Respiratory Medicine: 16 works · 14.7% of their workRadiology, Nuclear Medicine and Imaging: 11 works · 9.8% of their workEverything else: 37 works · 33.2% of their workLife Sciences: 27 works · 24.5% of their workBiochemistry, Genetics and Molecular Biology: 22 works · 19.6% of their workMolecular Biology: 12 works · 11.0% of their workCancer Research: 10 works · 8.6% of their workImmunology and Microbiology: 5 works · 4.9% of their workImmunology: 5 works · 4.9% of their workTHEIR WORKChristopherMontemagno112works
Life Sciences24%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4742.3%
  2. Everything else3733.2%
    1. Biochemistry, Genetics and Molecular Biology2219.6%
    2. Immunology and Microbiology54.9%
  1. 1Oncology18% of their works
  2. 2Pulmonary and Respiratory Medicine15% of their works
  3. 3Molecular Biology11% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Cancer Research9% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Christopher Montemagno's research?

The keywords of their largest research topics: Immunotherapy, Genetic Mutations, PET Imaging, Radiopharmaceuticals, endothelial progenitor cells, VEGF, Cancer Stem Cells and Tumor Metastasis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immunotherapy173 topics
  2. Genetic Mutations122 topics
  3. PET Imaging121 topic
  4. Radiopharmaceuticals121 topic
  5. VEGF111 topic
  6. endothelial progenitor cells111 topic
  7. Cancer Stem Cells71 topic
  8. Tumor Metastasis71 topic
  9. Androgen Receptor61 topic
  10. Metastatic61 topic
  11. Prostate Cancer61 topic
  12. Renal Cell Carcinoma61 topic
  13. Cell Adhesion51 topic
  14. Glioblastoma51 topic
  15. HIF-151 topic
  16. Integrins51 topic
  17. Temozolomide51 topic
  18. Warburg Effect51 topic

Where does Christopher Montemagno work?

Christopher Montemagno's main affiliation in the publication record is Scientific Centre of Monaco, Monaco.

How many publications and citations does Christopher Montemagno have?

OpenAlex counts 112 works and 754 citations for Christopher Montemagno, an h-index of 17, ranking #1,599,182 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christopher Montemagno. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.